Optimisation of the biology of soft tissue repair.
As identified in this review, over the past twenty years there have been a number of very exciting new developments in the quest to optimise soft tissue repair. Comparing fetal soft tissue injuries, which heal by regeneration, to the adult processes of healing by inflammation-induced scar formation has led to a number of insights into how the latter may be improved. Seeding wounds with embryonic stem cells, bridging gaps with cell-derived "engineered tissues", addition of exogenous hyaluronic acid and modification of wounds to either enhance the growth factors which have been implicated in regeneration (e.g. TGF-B3) or block those implicated in scar formation (eg. TGF-B1) have all shown promise. Our group has quantified numerous cellular, molecular, biomechanical and matrix abnormalities of scar in a rabbit model of ligament healing. Based on these studies which we review here, three matrix deficiencies have been identified which appear to have specific implications to scar weakness: organisational "flaws", abnormal hydroxypyridinoline collagen cross-link densities and abnormally small, slow-maturing collagen fibrils. In tests aimed at finding therapeutic solutions in this model, the addition of a 7ug bolus of TGF-B1 at day 21 or 2.5ng/day of TGF-B1 being pumped into a wound x 21 days increased the size of ligament scars but did not improve their material strength. It also did not alter any of the above-noted matrix deficiencies. A liposome-mediated anti-sense gene therapy approach aimed at decreasing the expression of the proteoglycan decorin in 21-day scars, however, has significantly increased the size of scar collagen fibrils as well as improved these scars mechanically. Based on these positive results from a single dose of only one targeted molecule, we believe that this gene therapy approach has great potential for further scar improvement. If combined with some of the other biological strategies reviewed above, a repair which is closer to true regenerative healing of ligaments, and all soft tissues, may eventually be achieved.
Frank
C
C
McCaig Centre for Joint Injury and Arthritis Research, Faculties of Medicine and Engineering, University of Calgary, Alberta, Canada.
Shrive
N
N
Hiraoka
H
H
Nakamura
N
N
Kaneda
Y
Y
Hart
D
D
D000818:Animals; D002921:Cicatrix / Q000503:physiopathology; D016207:Cytokines / Q000502:physiology; D005333:Fetus / Q000502:physiology; D015316:Genetic Therapy; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D006820:Hyaluronic Acid / Q000502:physiology; D017888:Medial Collateral Ligament, Knee / Q000293:injuries / Q000502:physiology; D011817:Rabbits; D017695:Soft Tissue Injuries / Q000503:physiopathology*; D014945:Wound Healing / Q000502:physiology*
D016207:Cytokines; D006133:Growth Substances; D006820:Hyaluronic Acid